RA CAPITAL MANAGEMENT, L.P.
Q3 2026 13F-HR Holdings
Net value change ($000)
-1,538,112
(-13.4%)
New positions
21
Sold out positions
13
Turnover %
17.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| FREENOME INC | 242,035 | NEW |
| PARABILIS MEDICINES INC | 150,250 | 19.0% |
| AMLX | 124,529 | NEW |
| WAVE LIFE SCIENCES INC | 99,809 | NEW |
| LATIGO BIOTHERAPEUTICS INC | 88,559 | NEW |
| OBSIDIAN THERAPEUTICS INC | 81,791 | NEW |
| DAMORA THERAPEUTICS INC | 51,066 | NEW |
| XNCR | 46,677 | 55.0% |
| DBVT | 43,014 | NEW |
| VOR | 41,711 | 94.3% |
Top Reduces (Value $000, Stocks/ETFs)
| SION | -401,763 | -92.2% |
| Ascendis Pharma AS | -399,848 | -14.6% |
| BCRX | -158,272 | -100.0% |
| WAVE LIFE SCIENCES LTD | -156,728 | -100.0% |
| NUVL | -153,937 | -100.0% |
| TYRA | -122,840 | -31.5% |
| GHRS | -120,539 | -58.7% |
| RYTM | -105,436 | -14.2% |
| NAMS | -91,395 | -28.2% |
| BCAX | -80,396 | -37.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|